Ángela Puente

3.6k total citations · 1 hit paper
77 papers, 1.6k citations indexed

About

Ángela Puente is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Ángela Puente has authored 77 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hepatology, 30 papers in Epidemiology and 16 papers in Surgery. Recurrent topics in Ángela Puente's work include Liver Disease and Transplantation (31 papers), Liver Disease Diagnosis and Treatment (23 papers) and Bone health and osteoporosis research (10 papers). Ángela Puente is often cited by papers focused on Liver Disease and Transplantation (31 papers), Liver Disease Diagnosis and Treatment (23 papers) and Bone health and osteoporosis research (10 papers). Ángela Puente collaborates with scholars based in Spain, Italy and Switzerland. Ángela Puente's co-authors include P Oriente, Raffaele Scarpa, Javier Crespo, Càndid Villanueva, Emilio Fábrega, José Ignacio Fortea, Virginia Hernández–Gea, María Poca, Isabel Graupera and Paula Iruzubieta and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Food Chemistry.

In The Last Decade

Ángela Puente

73 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease

2024 65 citations José Luís Calleja, Paula Iruzubieta et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by Ángela Puente

Since Specialization

Citations

This map shows the geographic impact of Ángela Puente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ángela Puente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ángela Puente more than expected).

Fields of papers citing papers by Ángela Puente

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ángela Puente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ángela Puente. The network helps show where Ángela Puente may publish in the future.

Co-authorship network of co-authors of Ángela Puente

This figure shows the co-authorship network connecting the top 25 collaborators of Ángela Puente. A scholar is included among the top collaborators of Ángela Puente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ángela Puente. Ángela Puente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Refining the Baveno VII criteria for clinically significant portal hypertension: An individual patient data meta-analysis 2025 ·Journal of Hepatology ·(unknown), Mònica Pons, Thomas Reiberger, Mattias Mandorfer, Mathias Jachs, Georg Semmler, Antonio Colecchia, Luigi Colecchia, Elton Dajti, Christophe Bureau, Hélène Larrue, Ivica Grgurević, (unknown), José Ignacio Fortea, Ángela Puente, Annalisa Berzigotti, Emmanuel Tsochatzis, Jaime Bosch, Juan G. Abraldeṣ, Joan Genescà	0
2	Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to β-blockers: A double-blind, placebo-controlled, randomized trial 2024 ·Hepatology ·Edilmar Alvarado‐Tápias, Anna Brujats, Ángela Puente, Alba Ardèvol, (unknown), Javier Antonio Tamayo Fajardo, Oana Pavel, (unknown), Carles Aracil, María Poca, (unknown), Elisabet Cantó, (unknown), Álvaro García‐Osuna, Àngels Escorsell, Xavier Torras, (unknown)	6
3	Risk of Recurrence of Hepatocarcinoma after Liver Transplantation: Performance of Recurrence Predictive Models in a Cohort of Transplant Patients 2023 ·Journal of Clinical Medicine ·Antonio Cuadrado, José Ignacio Fortea, Carlos Rodríguez de Lope, Ángela Puente, (unknown), (unknown), Federico Castillo, (unknown), Juan Echeverri, Mar Achalandabaso Boira, Enrique Toledo, (unknown), (unknown), Javier Crespo, Emilio Fábrega	2
4	High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic‐associated fatty liver disease 2023 ·Liver International ·(unknown), Ángela Puente, Antonio Cuadrado, Paula Iruzubieta, M. Arias, Carlos Redondo, (unknown), Emilio Fábrega, Javier Crespo, José Ignacio Fortea	13
5	CD64 expression on neutrophils as a potential biomarker for bacterial infection in ascitic fluid of cirrhotic patients 2023 ·Infectious Diseases ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Juan Irure‐Ventura, Ángela Puente, Marcos López‐Hoyos, José Ignacio Fortea, David San Segundo	1
6	Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review 2022 ·Journal of Clinical Medicine ·(unknown), Ángela Puente, Antonio Cuadrado, (unknown), (unknown), (unknown), (unknown), Emilio Fábrega, Javier Crespo, José Ignacio Fortea	9
7	Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy 2022 ·SHILAP Revista de lepidopterología ·Marco Tasso, (unknown), (unknown), (unknown), (unknown), Ángela Puente, (unknown), Francesco Santelli, Raffaele Scarpa, Luisa Costa, Francesco Caso	1
8	Congestive Hepatopathy 2020 ·International Journal of Molecular Sciences ·José Ignacio Fortea, Ángela Puente, Antonio Cuadrado, Patrícia Huelin, (unknown), (unknown), Marta Mayorga, (unknown), Inés Carrera, (unknown), Javier Crespo, Emilio Fábrega	44
9	Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension 2020 ·Journal of Hepatology ·Sabela Lens, Anna Baiges, Edilmar Alvarado‐Tápias, Elba Llop, Javier Martínez, José Ignacio Fortea, Luis Ibáñez, Zoe Mariñó, Sergio Rodríguez‐Tajes, Adolfo Gallego, Rafael Bañares, Ángela Puente, Agustı́n Albillos, José Luís Calleja, Xavier Torras, Virginia Hernández–Gea, Jaume Bosch, Càndid Villanueva, Juan Carlos García‐Pagán, Xavier Forns	100
10	Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders 2020 ·Journal of Clinical Medicine ·José Ignacio Fortea, Inés Carrera, Ángela Puente, Antonio Cuadrado, Patrícia Huelin, (unknown), (unknown), (unknown), (unknown), A. B. Lopez, (unknown), Marcos López‐Hoyos, Javier Crespo, Emilio Fábrega	15
11	Is Routine Prophylaxis Against Pneumocystis jirovecii Needed in Liver Transplantation? A Retrospective Single-Centre Experience and Current Prophylaxis Strategies in Spain 2020 ·Journal of Clinical Medicine ·José Ignacio Fortea, Antonio Cuadrado, Ángela Puente, (unknown), Patrícia Huelin, (unknown), Inés Carrera, (unknown), (unknown), Jorge Calvo, Carlos Ruiz de Alegría Puig, (unknown), Federico Castillo, (unknown), (unknown), Fernando Casafont, Javier Crespo, Emilio Fábrega	11
12	Changes in Circulating Lysyl Oxidase-Like-2 (LOXL2) Levels, HOMA, and Fibrosis after Sustained Virological Response by Direct Antiviral Therapy 2019 ·Journal of Clinical Medicine ·Ángela Puente, José Ignacio Fortea, (unknown), (unknown), (unknown), Joaquín Cabezas, M. Arias, Susana Llerena, Paula Iruzubieta, Emilio Fábrega, Javier Crespo	6
13	LOXL2—A New Target in Antifibrogenic Therapy? 2019 ·International Journal of Molecular Sciences ·Ángela Puente, José Ignacio Fortea, Joaquín Cabezas, M. Arias, Paula Iruzubieta, Susana Llerena, Patrícia Huelin, Emilio Fábrega, Javier Crespo	57
14	Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It 2019 ·Cells ·Ángela Puente, José Ignacio Fortea, (unknown), Patrícia Huelin, (unknown), (unknown), Joaquín Cabezas, M. Arias, Paula Iruzubieta, Antonio Cuadrado, Susana Llerena, Carlos López, Emilio Fábrega, Javier Crespo	20
15	Management of haemostatic alterations and associated disorders in cirrhosis in Spain: A national survey 2018 ·Digestive and Liver Disease ·José Ignacio Fortea, Ángela Puente, (unknown), Antonio Cuadrado, M. Arias, Joaquín Cabezas, Susana Llerena, Paula Iruzubieta, Carlos Rodríguez de Lope, Patrícia Huelin, Fernando Casafont, Emilio Fábrega, Javier Crespo	8
16	Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver 2017 ·Gastroenterología y Hepatología (English Edition) ·Marta Martín–Llahí, Agustı́n Albillos, Rafael Bañares, Annalisa Berzigotti, Ángeles García‐Criado, Joan Genescà, Virginia Hernández–Gea, (unknown), (unknown), José Mateo, C.A. Navascués, Ángela Puente, Marta Romero-Gutiérrez, Macarena Simón‐Talero, Luís Téllez, Fanny Turón, Cándido Villanueva, Roberto Zarrabeitia, Juan Carlos García‐Pagán	15
17	Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease 2016 ·International Journal of Molecular Sciences ·M. Arias, Paula Iruzubieta, Ángela Puente, David Ramos‐Barbón, (unknown), Á. Estébanez, Susana Llerena, Carmen Alonso-Martín, David San Segundo, (unknown), (unknown), Emilio Fábrega, Marcos López‐Hoyos, Javier Crespo	28
18	Influence of heat pre-treatment on BSA tryptic hydrolysis and peptide release 2016 ·Food Chemistry ·Fátima Arrutia, Ángela Puente, Francisco A. Riera, (unknown), (unknown)	28
19	Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review 2013 ·Liver International ·Ángela Puente, Virginia Hernández–Gea, Isabel Graupera, Marta Roqué i Figuls, Alan Colomo, María Poca, Carles Aracil, Ignasi Gich, Carlos Guarner, Càndid Villanueva	84
20	Evaluación de alternativas para disminuir los niveles de hongos fitopatógenos del suelo en áreas de replantación de cítricos 2011 ·(unknown), (unknown), Ángela Puente, (unknown), G. Rodríguez	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact